Answers are grounded in this paper and cite their sources.
Prospective analysis reveals no significant graft structural differences in chronic kidney disease patients, indicating implications for graft management.
OBJECTIVES Chronic kidney disease (CKD) is associated with metabolic dysfunctions that accelerate atherosclerosis, posing significant challenges for patients undergoing coronary artery bypass grafting (CABG). In this population, arterial calcification and reduced saphenous vein patency are common complications. This multicentre prospective study aims to evaluate the impact of renal dysfunction on the histological characteristics of arterial and venous grafts used in CABG. METHODS Vascular graft specimens collected during CABG were prospectively analyzed and stratified into three groups based on renal function, according to established publications: Group 1 (GFR ≥90 ml/min/1.73m2), Group 2 (GFR 60–89 ml/min/1.73m2), and Group 3 (GFR ≤59 ml/min/1.73m2). Formalin-fixed samples were histologically assessed for intimal thickening (Grade 0–3), fibroelastosis, and vasa vasorum density. RESULTS A total of 324 arterial grafts (Group 1: 100; Group 2: 134; Group 3: 90) and 289 vein grafts (Group 1: 86; Group 2: 119; Group 3: 84) were analyzed, including five arterial and venous grafts from dialysis patients. No significant structural differences were observed between groups. Intimal thickening rates was comparable across renal function stages. Fibroelastosis was more prevalent in venous grafts (56–64%) than in arterial grafts (10–15%). CONCLUSIONS This study assesses graft histology in CABG patients stratified by renal function. At surgery, CKD does not appear to significantly alter graft structure. Further studies are warranted to explore long-term graft outcomes in this population.
No takes yet. Share an insight, caveat, or question.
Grazioli et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: